Alimera Sciences (ALIM) Price/Sales Ratio

Price: $5.54
Market Cap: $301.29M
Avg Volume: 866.83K
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 1.245
52W Range: $2.606-5.65
Website: Alimera Sciences

What is Alimera Sciences's Price/Sales Ratio?

  • Alimera Sciences's trailing twelve month (TTM) Price/Sales ratio is 3.02.
  • Alimera Sciences's annual Price/Sales ratio as of today is 1.37.
  • Alimera Sciences's quarterly Price/Sales ratio is 11.12.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess Alimera Sciences's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -5.49
    • Quarterly: -22.67
    • TTM: -20.50
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 2.39
    • Quarterly: 7.74
    • TTM: 7.77
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -7.74
    • Quarterly: 292.59
    • TTM: -53.84
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: 0.08
    • Quarterly: 0.51
    • TTM: -0.25

These metrics provide insights into Alimera Sciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

1.37

Quarterly Price/Sales Ratio

11.12

TTM Price/Sales Ratio

3.02

Alimera Sciences Historical Price/Sales Ratio
28.0028.0021.0021.0014.0014.007.007.000.000.00Price/Sales Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical P/E Ratio
0.000.00-2.00-2.00-4.00-4.00-6.00-6.00-8.00-8.00P/E Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical P/B Ratio
24.0024.0016.0016.008.008.000.000.00-8.00-8.00-16.00-16.00P/B Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical P/C Ratio
0.000.00-3.00-3.00-6.00-6.00-9.00-9.00-12.00-12.00P/C Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical PEG Ratio
0.250.250.210.210.170.170.130.130.080.080.040.04-0.00-0.00PEG Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024

Alimera Sciences Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2023 1.37 -5.49 2.39 -7.74 0.08
2022 0.35 -1.05 -0.91 -1.90 0.00
2021 0.57 -7.74 -12.99 -10.49 0.21
2020 0.42 -4.05 -2.71 -9.85 0.08
2019 0.67 -3.46 -8.13 -8.71 0.09
2018 1.07 -3.07 18.47 -4.35 0.11
2017 2.48 -4.05 5.97 -6.92 0.08
2016 1.66 -1.72 2.23 -2.27 0.19
2015 4.79 -3.51 4.09 -2.37 0.16
2014 26.57 -6.23 4.52 -9.21 0.16

Related Metrics

Explore detailed financial metrics and analysis for ALIM.